Company Filing History:
1 out of 183 
1 out of 34 Years Active: 2025
Title: The Innovative Contributions of Hou-Chen Lee
Introduction
Hou-Chen Lee is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of immunology, particularly in relation to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). His work focuses on methods for determining immune competence against this virus, which has become increasingly relevant in recent times.
Latest Patents
Hou-Chen Lee holds a patent for a method that determines immune competence against SARS-CoV-2. This method involves obtaining a blood sample from a subject, detecting levels of binding antibodies against the SARS-CoV-2 spike S1 protein and its receptor binding domain (RBD), and calculating a weighted value using a regression model. This innovative approach provides valuable insights into the immune response to the virus.
Career Highlights
Throughout his career, Hou-Chen Lee has been associated with prestigious institutions such as Chang Gung University and Chang Gung Memorial Hospital in Linkou. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to important research initiatives.
Collaborations
One of his notable collaborators is Kuan-Ting Liu. Their partnership has likely facilitated advancements in their shared research interests and has contributed to the development of innovative solutions in immunology.
Conclusion
Hou-Chen Lee's contributions to the field of immunology, particularly through his patent related to SARS-CoV-2, highlight his role as an influential inventor. His work continues to impact the understanding of immune competence against viral infections.